Chidamide in the treatment of peripheral T-cell lymphoma

Overview of attention for article published in OncoTargets and therapy, January 2017

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Above-average Attention Score compared to outputs of the same age and source (62nd percentile)

Mentioned by

patent: 1 patent

Citations

dimensions_citation: 61 Dimensions

Readers on

mendeley: 36 Mendeley

Summary Patents Dimensions citations

So far, Dimensions has found 61 publications that cite this research output.

61

The most recent citing publications are shown below. View all 61 publications that cite this research output on Dimensions.

Integration of caveolin-mediated cytosolic delivery and enzyme-responsive releasing of squalenoyl nanoparticles enhance the anti-cancer efficacy of chidamide in pancreatic cancer

Article in International Journal of Pharmaceutics (March 2024)

Epigenetic meets metabolism: novel vulnerabilities to fight cancer

Article in Cell Communication and Signaling (September 2023)

Clinical features and prognostic outcomes of angioimmunoblastic T cell lymphoma in an Asian multicenter study

Article in Leukemia & Lymphoma (July 2023)